The largest database of trusted experimental protocols

3 protocols using mcf10a

1

YAP Depletion in MCF10A Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF10A (American Type Culture Collection), nontumorigenic human breast epithelial cells, MCF10A with anti-YAP short hairpin RNA (shRNA) (shYAP) (courtesy of G.D. Longmore, Washington University), and mutant MCF10A cells overexpressing ErbB2 (kindly provided by Dihua Yu), were cultured in DMEM/F12 (GE Healthcare Life Sciences), supplemented with 5% horse serum (Invitrogen), 20 ng/ml epidermal growth factor (EGF; Miltenyi Biotec), 0.5 mg/ml hydrocortisone (Sigma-Aldrich), 10 µg/ml insulin (Sigma-Aldrich), 100 ng/ml cholera toxin (Sigma-Aldrich), and 0.2 % Normocin (Invitrogen). Media was changed every 3 d while cells were in culture. For YAP depletion, the healthy MCF10A cell line was transfected using a lentiviral pFLRU vector containing anti-YAP shRNA, developed and verified in our previous work (Nasrollahi et al., 2017 (link)).
+ Open protocol
+ Expand
2

Breast Cancer Tissue and Cell Line Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 30 paired formalin-fixed paraffin-embedded human breast cancer tissue samples and adjacent non-cancerous tissue samples were obtained from the Department of Pathology of The Second Affiliated Hospital of Xi'an Jiaotong University (Xi'an, China) between May 2015 and December 2015. The patients were aged 35–79 years, with an average age of 59.0±12.7 years. No patients had received radiotherapy or chemotherapy prior to surgery. All the patients provided informed consent, and the study protocol was approved by the Ethics Committee of Xi'an Jiaotong University.
The human breast cancer cell lines, MCF-7 and MDA-MB-231, and the normal breast epithelial cell line MCF-10A, were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). MDA-MB-231 and MCF-7 cells were cultured in Dulbecco's modified Eagles medium (DMEM) supplemented with 10% foetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.). MCF-10A cells were maintained in DMEM/F12 medium (HyClone; GE Healthcare Life Sciences) with the addition of 10 µg/ml insulin, 20 ng/ml epidermal growth factor (Sigma-Aldrich; Merck KGaA) and 5% horse serum (Gibco; Thermo Fisher Scientific, Inc.). All cells were cultured in a humidified incubator at 37°C with 5% CO2.
+ Open protocol
+ Expand
3

Culturing Human Breast Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines and culture. Human breast cancer cell lines (MCF-7, BT474, MDA-MB-231, and MDA-MB-468), normal breast epithelial cell line MCF-10A and 293T cells were purchased from the American Type Culture Collection (Manassas, VA, USA). BT474 and MDA-MB-231 cells were cultured in Hyclone RPMI-1640 medium (GE Healthcare Life Sciences, Logan, UT, USA) while MCF-7, MDA-MB-468, MCF-10A and 293T cells were cultured in Hyclone Dulbecco's modified Eagle's medium (GE Healthcare Life Sciences). All cells were grown in medium containing 10% fetal bovine serum (Hyclone; GE Healthcare Life Sciences) supplemented with 1% penicillin-streptomycin (Gibco; Thermo Fisher Scientific Inc., Waltham, MA, USA) in a humidified atmosphere of 5% CO 2 at 37˚C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!